Opticeuticals Inc. has formally positioned HelioMystique as the women's line under the HelioMend transdermal master brand. The HelioMend brand architecture encompasses multiple product lines across target demographics and delivery formats. HelioMystique occupies the women's skin restoration category within this architecture, delivering bioregulator dermatology protocols specifically formulated for the skin concerns most prevalent in women aged 35 to 55 — including firmness loss, barrier dysfunction, and the accelerated structural changes associated with perimenopause and menopause.